Mielczarek-Lewandowska, A., Sztiller-Sikorska, M., Osrodek, M., Czyz, M., & Hartman, M. L. (2019). 17-Aminogeldanamycin selectively diminishes IRE1α-XBP1s pathway activity and cooperatively induces apoptosis with MEK1/2 and BRAF(V600E) inhibitors in melanoma cells of different genetic subtypes. Apoptosis.
Chicago-tyylinen lähdeviittausMielczarek-Lewandowska, Aleksandra, Malgorzata Sztiller-Sikorska, Marta Osrodek, Malgorzata Czyz, ja Mariusz L. Hartman. "17-Aminogeldanamycin Selectively Diminishes IRE1α-XBP1s Pathway Activity and Cooperatively Induces Apoptosis With MEK1/2 and BRAF(V600E) Inhibitors in Melanoma Cells of Different Genetic Subtypes." Apoptosis 2019.
MLA-viiteMielczarek-Lewandowska, Aleksandra, et al. "17-Aminogeldanamycin Selectively Diminishes IRE1α-XBP1s Pathway Activity and Cooperatively Induces Apoptosis With MEK1/2 and BRAF(V600E) Inhibitors in Melanoma Cells of Different Genetic Subtypes." Apoptosis 2019.